The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

Status unconfirmed

Conditions studied: COVID-19, Lyme Disease, COVID-19 Vaccine

In brief

A cross-sectional descriptive survey of the BOLD for individuals after having been ill with COVID-19 or have taken the COVID-19 vaccine will be compared with that of individuals who have neither been ill with COVID-19 nor taken the COVID-19 vaccine. Individuals who have both been ill and taken the COVID-19 vaccine will be compared to identify any additive risk factors.

Key facts

Study ID

NCT05312619

Run by

Dr. Daniel Cameron & Associates

People needed

2000

Starts

2021-07-07

Expected to finish

2023-11-07

Last updated by the study team

2022-04-05

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥12 years old
• a self-report of having been diagnosed with Lyme disease.

You may not qualify if…

• There are no exclusion criteria.

Where it is running

• Daniel Cameron — Mount Kisco, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.